TRADES
Latest Trades
56
results found
FUND
DATE
ACTION
TICKER
COMPANY
SHARES
% of ETF
ARKG 9 Jun 2021 Sell SYRS SYROS PHARMACEUTICALS INC 911 0.0001
ARKK 8 Jun 2021 Sell SYRS SYROS PHARMACEUTICALS INC 913 0.0000
ARKG 7 Jun 2021 Sell SYRS SYROS PHARMACEUTICALS INC 5,500 0.0004
ARKK 7 Jun 2021 Sell SYRS SYROS PHARMACEUTICALS INC 5,000 0.0001
ARKK 4 Jun 2021 Sell SYRS SYROS PHARMACEUTICALS INC 10,000 0.0003
ARKK 27 May 2021 Sell SYRS SYROS PHARMACEUTICALS INC 80,000 0.0022
ARKK 26 May 2021 Sell SYRS SYROS PHARMACEUTICALS INC 3,574,908 0.0905
ARKK 24 May 2021 Sell SYRS SYROS PHARMACEUTICALS INC 12,700 0.0003
ARKK 21 May 2021 Sell SYRS SYROS PHARMACEUTICALS INC 83,146 0.0023
ARKG 20 May 2021 Sell SYRS SYROS PHARMACEUTICALS INC 45,000 0.0033
ARKG 18 May 2021 Sell SYRS SYROS PHARMACEUTICALS INC 300,000 0.0206
ARKG 14 May 2021 Sell SYRS SYROS PHARMACEUTICALS INC 204,414 0.0141
ARKG 13 May 2021 Sell SYRS SYROS PHARMACEUTICALS INC 400,000 0.0288
ARKG 12 May 2021 Sell SYRS SYROS PHARMACEUTICALS INC 147,332 0.0102
ARKG 11 May 2021 Sell SYRS SYROS PHARMACEUTICALS INC 66,857 0.0044
ARKG 7 May 2021 Sell SYRS SYROS PHARMACEUTICALS INC 109,554 0.0069
ARKG 6 May 2021 Sell SYRS SYROS PHARMACEUTICALS INC 96,092 0.0062
ARKG 5 May 2021 Sell SYRS SYROS PHARMACEUTICALS INC 9,670 0.0006
ARKG 28 Apr 2021 Sell SYRS SYROS PHARMACEUTICALS INC 14,945 0.0010
ARKG 27 Apr 2021 Sell SYRS SYROS PHARMACEUTICALS INC 376,429 0.0249
ARKG 26 Apr 2021 Sell SYRS SYROS PHARMACEUTICALS INC 58,782 0.0039
ARKG 23 Apr 2021 Sell SYRS SYROS PHARMACEUTICALS INC 55,616 0.0037
ARKG 22 Apr 2021 Sell SYRS SYROS PHARMACEUTICALS INC 100,143 0.0067
ARKG 21 Apr 2021 Sell SYRS SYROS PHARMACEUTICALS INC 47,382 0.0030
ARKG 16 Apr 2021 Sell SYRS SYROS PHARMACEUTICALS INC 100 0.0000
ARKG 15 Apr 2021 Sell SYRS SYROS PHARMACEUTICALS INC 5,871 0.0004
ARKG 14 Apr 2021 Sell SYRS SYROS PHARMACEUTICALS INC 114,600 0.0079
ARKG 13 Apr 2021 Sell SYRS SYROS PHARMACEUTICALS INC 71,392 0.0047
ARKG 12 Apr 2021 Sell SYRS SYROS PHARMACEUTICALS INC 401 0.0000
ARKG 8 Apr 2021 Sell SYRS SYROS PHARMACEUTICALS INC 3,833 0.0003
ARKG 5 Apr 2021 Sell SYRS SYROS PHARMACEUTICALS INC 68,057 0.0052
ARKG 1 Apr 2021 sell SYRS SYROS PHARMACEUTICALS INC 35,756 0.0030
ARKG 31 Mar 2021 Sell SYRS SYROS PHARMACEUTICALS INC 102,526 0.0082
ARKG 30 Mar 2021 Sell SYRS SYROS PHARMACEUTICALS INC 49,951 0.0042
ARKG 29 Mar 2021 Sell SYRS SYROS PHARMACEUTICALS INC 22,186 0.0019
ARKG 7 Dec 2020 Sell SYRS SYROS PHARMACEUTICALS INC 135,992 0.0249
ARKG 4 Dec 2020 Sell SYRS SYROS PHARMACEUTICALS INC 38,400 0.0066
ARKG 1 Dec 2020 Sell SYRS SYROS PHARMACEUTICALS INC 42,400 0.0084
ARKG 30 Nov 2020 Sell SYRS SYROS PHARMACEUTICALS INC 26,518 0.0054
ARKG 27 Nov 2020 Sell SYRS SYROS PHARMACEUTICALS INC 11,284 0.0023
ARKG 24 Nov 2020 Sell SYRS SYROS PHARMACEUTICALS INC 17,901 0.0040
ARKG 23 Nov 2020 Sell SYRS SYROS PHARMACEUTICALS INC 25,320 0.0056
ARKG 20 Nov 2020 Sell SYRS SYROS PHARMACEUTICALS INC 49,919 0.0100
ARKG 17 Nov 2020 Sell SYRS SYROS PHARMACEUTICALS INC 13,678 0.0035
ARKG 16 Nov 2020 Sell SYRS SYROS PHARMACEUTICALS INC 100 0.0000
ARKG 13 Nov 2020 Sell SYRS SYROS PHARMACEUTICALS INC 4,970 0.0013
ARKG 12 Nov 2020 Sell SYRS SYROS PHARMACEUTICALS INC 18,158 0.0049
ARKG 11 Nov 2020 Sell SYRS SYROS PHARMACEUTICALS INC 27,653 0.0070
ARKG 9 Nov 2020 Sell SYRS SYROS PHARMACEUTICALS INC 46,851 0.0142
ARKG 5 Nov 2020 Sell SYRS SYROS PHARMACEUTICALS INC 44,198 0.0114
ARKG 4 Nov 2020 Sell SYRS SYROS PHARMACEUTICALS INC 113,271 0.0317
ARKK 3 Nov 2020 Sell SYRS SYROS PHARMACEUTICALS INC 697,201 0.0497
ARKK 2 Nov 2020 Sell SYRS SYROS PHARMACEUTICALS INC 230,929 0.0165
ARKK 29 Oct 2020 Sell SYRS SYROS PHARMACEUTICALS INC 379,039 0.0264
ARKK 27 Oct 2020 Sell SYRS SYROS PHARMACEUTICALS INC 36,183 0.0024
ARKK 23 Oct 2020 Sell SYRS SYROS PHARMACEUTICALS INC 91,114 0.0100
Latest Blogs
Cathie Wood's ARK Invest sells nearly 34,000 shares of Tesla

On Monday, a large number of shares of an exchange-traded fund (ETF) managed by ETF star Cathie Wood were sold. In particular, this fund sold nearly 34,000 shares of Tesla Inc. (NASDAQ: TSLA), despite the fact that the fund's price had increased by more than 1 percent on the day. It should be noted that the fund has experienced a significant decline over the past year.

 

The ARK Innovation ETF (NYSEARCA: ARKK) was responsible for the sale of 33,919 shares of Tesla. At Monday's closing price, the transaction would have been valued at approximately $34.2 million. Despite the fact that this represents a small portion of the total holdings, every little bit helps. In the last year, the fund has lost 17 percent of its value.

 

Cathie Wood's ARK Transparency ETF (CTRU) is preparing to make its debut on Wednesday, according to the company.

In preparation for Cathie Wood's launch of the ARK Transparency ETF, financial markets are bracing themselves (BATS: CTRU). CTRU is set to launch on Wednesday and will aim to provide investors with exposure to stocks that exhibit the highest levels of transparency, openness, communication, and trust in their operations.

ARK believes that greater transparency fosters greater consumer confidence while also providing investors with long-term growth potential. Because of this, CTRU is designed to track the price movements of the Transparency Index on a continuous basis. The cumulative returns of the S & P 500 and the Transparency Index from October 1, 2016, to September 30, 2021, are depicted in the chart below.

The new fund will have an expense ratio of 0.55 percent, which is lower than the current one. Furthermore, the ETF will have 100 holdings, with the top three holdings being Cloudflare (NYSE: NET), Bloom Energy (NYSE: BE), and Enphase Energy (NYSE: E) (NASDAQ: ENPH). The top holdings and weightings of CTRU are detailed in the fund's fact sheet.

CTRU will be the ninth exchange-traded fund (ETF) launched by ARK Invest and the third index-based ETF. The fund will trade alongside Wood's flagship fund, the ARK Innovation ETF (NYSEARCA: ARKK), which has amassed over $16 billion in assets under management as of the end of September.

The market's reaction to CTRU's unveiling will be determined in due course. If you're interested in a comparison, Wood's most recent ETF launch, the actively managed ARK Space Exploration & Innovation ETF (BATS: ARKX), saw $295 million worth of value traded in its initial public offering on March 30, 2021.

Although her actively managed exchange-traded funds have performed well this year, Wood's newest fund addition will be launched at a time when the sector has been under fire.

 

The Ark of Cathie Wood Invest falls into a bear market as tech bets turn sour.

Ark Invest's flagship Trade-traded fund has seen its losses for the year soar to 26 cents for every dollar invested, as investors sell off the high-growth but typically unprofitable technology stocks that were responsible for the fund's meteoric rise.

Ark Innovation, owned by trader Cathie Wood, opened down four cents on Monday, following a 12.6 cent decrease the previous week, the company's lowest seven-day stretch since February. Since its February high, the ETF has lost more than 40 cents for every dollar invested.

Ark Innovation is a $21.4 billion actively managed exchange-traded fund that invests in corporations in the United States that are pursuing "disruptive innovation," particularly in areas such as DNA systems, automation, robotics, and electrical power storage, synthetic intelligence, and financial technology.

In the past year, some of Ark's most valuable investments have been hammered, including the real estate marketplace Zillow, the virtual health care organization Teladoc, Zoom — the video clip meeting platform that was just one of the big winners of the pandemic — and Roku, a television streaming company.

 

AJ Bell, the UK's second-largest shown spending platform, claimed that "there has been a waning of enthusiasm for higher-growth tech companies." Russ Mould, the company's financial commitment director, said that A large portion of Ark Innovations' holdings is losing money, which is not ideal in an environment when interest rates are expected to climb.

Although Tesla, Ark's lone most prominent position, has recently weakened, its broad 2021 decline would have been substantially worse had it not been for the company's strong performance in 2018. Tesla is up 38 percent this year despite recent weakness.

Ark Innovation, according to Mould, has faced "some inventory-certain concerns, which have exposed some expensive valuations," in addition to risky technology stocks falling out of favor with investors.

Read full article https://www.clearpublicist.com/cathie-woods-ark-invest-slumps-to-bear-market-as-tech-bets-bitter/.